Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (RLAY)

CUSIP: 75943R102

Q2 2024 13F Holders as of 30 Jun 2024

Holder snapshot 7 signals
Share change
-5,523,095
Put/Call ratio
1059%
SEC-reported price per share
$6.52
Number of holders
171
Value change
-$42,426,305
Number of buys
91
Open additional details 1 more signal available
Number of sells
78
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
4,389,099

Security key

75943R102

Report period

Q2 2024

Institutions

171

Top holders

10

Ownership snapshot

Top reported holders of RLAY - Relay Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
SB INVESTMENT ADVISERS (U...
Disclosed value leader
SB INVESTMENT ADVISERS (U...
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F Lead comparable stake: 636% Showing 1-6 of 15 holder rows.

Quick read

SB INVESTMENT ADVISERS (UK) LTD leads the comparable SEC ownership view at 636%.

15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens SB INVESTMENT ADVISERS (UK) LTD's linked filing trail.
Comparable ownership Top 5
SB INVESTMENT ADVISERS (UK) LTD 636%
VANGUARD GROUP INC 269%
BlackRock Finance, Inc. 223%
Casdin Capital, LLC 169%
PRICE T ROWE ASSOCIATES INC /MD/ 157%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
SB INVESTMENT ADVISERS (UK) LTD
13F
Company
13F
636%
$231,611,193
27,904,963 shares
31 Mar 2024
VANGUARD GROUP INC
13F
Company
13F
269%
$98,070,053
11,815,669 shares
31 Mar 2024
BlackRock Finance, Inc.
13F
Company
13F
223%
$81,308,545
9,796,210 shares
31 Mar 2024
Casdin Capital, LLC
13F
Company
13F
169%
$61,615,664
7,423,574 shares
31 Mar 2024
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
13F
157%
$57,101,000
6,879,597 shares
31 Mar 2024
STATE STREET CORP
13F
Company
13F
137%
$49,974,200
6,020,988 shares
31 Mar 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
171
Shares
126,697,163
Rows available
171
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
182
Q2 2024 holders
171
Holder diff
-11
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 value Q2 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .